ALGS - Aligos Therapeutics, Inc.

6.98
0.320   4.585%

Share volume: 87,186
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.19%

PREVIOUS CLOSE
CHG
CHG%
$6.66
0.32
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-06-2024 11-06-2024 03-10-2025 05-06-2025 11-06-2025 03-05-2026
Total revenue 986.000 K 1.061 M 1.269 M 629.000 K 311.000 K 741.000 K 169.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 986.000 K 1.061 M 1.269 M 629.000 K 311.000 K 741.000 K 169.000 K
    7.61% 19.60% -50.43% -50.56% 138.26% -77.19%  
Operating expenses 23.032 M 27.475 M 21.400 M 21.192 M 19.554 M 29.102 M 21.983 M
Selling general and admin 6.666 M 6.376 M 4.626 M 5.162 M 5.052 M 5.165 M 4.945 M
Research and development 16.366 M 21.099 M 16.774 M 16.030 M 14.502 M 23.937 M 17.038 M
Total expenses 23.032 M 27.475 M 21.400 M 21.192 M 19.554 M 29.102 M 21.983 M
    19.29% -22.11% -0.97% -7.73% 48.83% -24.46%  
Operating income -22.046 M -26.414 M -20.131 M -20.563 M -19.243 M -28.361 M -21.814 M
Ebit -22.046 M 5.250 M -19.168 M -20.563 M 43.131 M -31.481 M -19.851 M
Pretax income -34.839 M 5.250 M -19.168 M -82.123 M 43.131 M -31.481 M -19.851 M
    -115.07% -465.10% 328.44% -152.52% -172.99% -36.94%  
Income tax 24.000 K 189.000 K 91.000 K 27.000 K 43.000 K 56.000 K 30.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -34.863 M 5.061 M -19.259 M -82.150 M 43.088 M -31.537 M -19.881 M
    114.52% -480.54% -326.55% 152.45% -173.19% 36.96%